Hansson E, Rönnbäck L
Institute of Neurobiology, University of Göteborg, Sweden.
Neuropharmacology. 1988 Mar;27(3):295-300. doi: 10.1016/0028-3908(88)90047-0.
Receptors for vasoactive intestinal peptide (VIP) were demonstrated with cyclic AMP as the second messenger on astroglial cells cultured from the cerebral cortex, striatum, hippocampus and brain stem of the newborn rat. Vasoactive intestinal peptide produced increased accumulations of cyclic AMP in nM and microM concentrations, the former more pronounced in the cultures of brain stem, while the latter was more pronounced in the other cultures studied, indicating regional differences in the activation of cyclic AMP of VIP receptors. Vasoactive intestinal peptide inhibited isoproterenol-induced accumulation of cyclic AMP dose-dependently, with some regional differences, suggesting interactions between the second messenger systems of beta- and VIP receptors. On the other hand, there was no inhibition of the NA-induced accumulation of cyclic AMP in the presence of VIP, which is in agreement with an interaction between the second messenger systems for VIP and the alpha-adrenoceptor. The data support interactions between the second messenger systems for VIP and alpha- and beta-adrenoceptors on cultured astrocytes. The functional implications are at present unknown, but it might be that the peptide can modulate the response of the second messenger to catecholamines on astroglial cells through intramembrane mechanisms.
在新生大鼠大脑皮层、纹状体、海马体和脑干培养的星形胶质细胞上,以环磷酸腺苷(cAMP)作为第二信使证实了血管活性肠肽(VIP)的受体。血管活性肠肽在纳摩尔和微摩尔浓度下均可使cAMP的积累增加,前者在脑干培养物中更为明显,而后者在其他研究的培养物中更为明显,这表明VIP受体激活cAMP存在区域差异。血管活性肠肽剂量依赖性地抑制异丙肾上腺素诱导的cAMP积累,存在一些区域差异,提示β受体和VIP受体的第二信使系统之间存在相互作用。另一方面,在VIP存在的情况下,去甲肾上腺素诱导的cAMP积累未受到抑制,这与VIP和α肾上腺素能受体的第二信使系统之间的相互作用一致。这些数据支持了培养的星形胶质细胞上VIP与α和β肾上腺素能受体的第二信使系统之间的相互作用。目前其功能意义尚不清楚,但可能是该肽可通过膜内机制调节星形胶质细胞上第二信使对儿茶酚胺的反应。